☆ 4.7 Editorial Material

IL-33 in clinical practice: Size matters?

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Get Full Text
Add to Collection

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 140, Issue 2, Pages 381-383

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2017.03.042

Keywords

IL-33; alarmin; innate lymphoid cell; biological activity

Categories

Allergy Immunology

Funding

  1. MSD(Merck Sharp and Dohme)
  2. Kyorin Pharmaceutical
  3. AstraZeneca
  4. Maruho
  5. Teijin Pharma
  6. Chugai Pharmaceutical
  7. Grants-in-Aid for Scientific Research [16K15515] Funding Source: KAKEN

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.